128 related articles for article (PubMed ID: 2896402)
1. The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. The Dutch TIA Study Group.
Stroke; 1988 Apr; 19(4):512-7. PubMed ID: 2896402
[TBL] [Abstract][Full Text] [Related]
2. Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group.
Stroke; 1993 Apr; 24(4):543-8. PubMed ID: 8465360
[TBL] [Abstract][Full Text] [Related]
3. We need stronger predictors of major vascular events in patients with a recent transient ischemic attack or nondisabling stroke. Dutch TIA Trial Study Group.
Dippel DW; Koudstaal PJ
Stroke; 1997 Apr; 28(4):774-6. PubMed ID: 9099195
[TBL] [Abstract][Full Text] [Related]
4. Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group.
Koudstaal PJ; Algra A; Pop GA; Kappelle LJ; van Latum JC; van Gijn J
Lancet; 1992 Sep; 340(8820):630-3. PubMed ID: 1355211
[TBL] [Abstract][Full Text] [Related]
5. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
[TBL] [Abstract][Full Text] [Related]
6. Does cerebral infarction after a previous warning occur in the same vascular territory?
Cillessen JP; Kappelle LJ; van Swieten JC; Algra A; van Gijn J
Stroke; 1993 Mar; 24(3):351-4. PubMed ID: 8446968
[TBL] [Abstract][Full Text] [Related]
7. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke.
; van Gijn J; Algra A; Kappelle J; Koudstaal PJ; van Latum A
N Engl J Med; 1991 Oct; 325(18):1261-6. PubMed ID: 1922220
[TBL] [Abstract][Full Text] [Related]
8. Controlled trial of aspirin in cerebral ischemia.
Fields WS; Lemak NA; Frankowski RF; Hardy RJ
Stroke; 1977; 8(3):301-14. PubMed ID: 324036
[TBL] [Abstract][Full Text] [Related]
9. Recurrent stroke after transient ischaemic attack or minor ischaemic stroke: does the distinction between small and large vessel disease remain true to type? Dutch TIA Trial Study Group.
Kappelle LJ; van Latum JC; van Swieten JC; Algra A; Koudstaal PJ; van Gijn J
J Neurol Neurosurg Psychiatry; 1995 Aug; 59(2):127-31. PubMed ID: 7629525
[TBL] [Abstract][Full Text] [Related]
10. [The Dutch TIA study of the preventive action of very low doses of acetylsalicylic acid and atenolol].
Frericks H
Ned Tijdschr Geneeskd; 1988 Feb; 132(7):312-4. PubMed ID: 3279327
[No Abstract] [Full Text] [Related]
11. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
12. Controlled trial of aspirin in cerebral ischemia.
Fields WS; Lemak NA; Frankowski RF; Hardy RJ; Bigelow RH
Circulation; 1980 Dec; 62(6 Pt 2):V90-6. PubMed ID: 7002356
[TBL] [Abstract][Full Text] [Related]
13. Silent infarction on a second CT scan in 91 patients without manifest stroke in the Dutch TIA trial.
Herderscheê D; Hijdra A; Algra A; Kappelle LJ; Koudstaal PJ; van Gijn J
Clin Neurol Neurosurg; 1994 Aug; 96(3):219-21. PubMed ID: 7988089
[TBL] [Abstract][Full Text] [Related]
14. [Low dose acetylsalicylic acid in secondary prevention of stroke].
Deecke L; Zeiler K
Wien Klin Wochenschr; 1993; 105(17):485-7. PubMed ID: 8212707
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose aspirin on functional outcome from cerebral vascular events in women.
Rist PM; Buring JE; Kase CS; Kurth T
Stroke; 2013 Feb; 44(2):432-6. PubMed ID: 23306328
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event.
Wang Y; Johnston SC;
Am Heart J; 2010 Sep; 160(3):380-386.e1. PubMed ID: 20826243
[TBL] [Abstract][Full Text] [Related]
17. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group.
Lancet; 1991 Nov; 338(8779):1345-9. PubMed ID: 1682734
[TBL] [Abstract][Full Text] [Related]
18. The European Stroke Prevention Study (ESPS): results by arterial distribution.
Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
[TBL] [Abstract][Full Text] [Related]
20. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. The Dutch TIA Trial Study Group.
Stroke; 1993 Apr; 24(4):527-31. PubMed ID: 8465356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
